首页 | 官方网站   微博 | 高级检索  
     

非小细胞肺癌患者围手术期血清VEGF水平变化与临床特征的关系
引用本文:胡瑛,李宝兰,韩毅,于大平,郭艳玲,石广利,高广阔,宋长兴. 非小细胞肺癌患者围手术期血清VEGF水平变化与临床特征的关系[J]. 肿瘤防治研究, 2010, 37(5): 535-539. DOI: 10.3971/j.issn.1000-8578.2010.05.013
作者姓名:胡瑛  李宝兰  韩毅  于大平  郭艳玲  石广利  高广阔  宋长兴
作者单位:101149 北京胸科医院综合科
摘    要:目的:研究非小细胞肺癌患者围手术期血清血管内皮生长因子的水平,探讨其变化与临床特征之间的关系。方法:应用酶联免疫吸附试验(enzyme linked immunosorbent assay,ELISA) 检测法,分别监测21例非小细胞肺癌及12例肺良性病患者手术前、后1、7、14、21及28天血清VEGF的浓度,30例健康志愿者确定血清VEGF正常水平。结果:(1)NSCLC患者术前血清VEGF浓度(649.20ng/L)显著高于肺良性疾病患者术前(140.70ng/L)及健康人血清水平(94.40ng/L)( P =0.000);(2)手术切除肿瘤后,NSCLC患者的血清VEGF水平比术前水平升高,术后第14天出现峰值(1963.6ng/L),比术前血清水平(649.20ng/L)明显升高( P =0.000),此后开始下降,术后28天时NSCLC患者血清VEGF水平(958.4ng/L)仍显著高于术前血清水平( P =0.000),显著高于肺良性病患者此时的血清水平( P =0.000);(3)NSCLC患者术前血清VEGF水平与肿瘤大小和分化程度相关( P <0.05),NSCLC患者围手术期血清VEGF动态变化与肿瘤大小、淋巴结转移及病理分期相关( P <0.05)。结论:非小细胞肺癌患者血清VEGF的术前水平显著高于肺良性病患者及健康人。围手术期血清VEGF水平显著升高;NSCLC患者术前血清VEGF水平与肿瘤大小和分化程度相关,NSCLC患者围手术期血清VEGF动态变化与肿瘤大小、淋巴结转移及病理分期相关。

关 键 词:血管内皮生长因子  非小细胞肺癌  酶联免疫吸附试验  围手术期  
收稿时间:2009-01-07
修稿时间:2009-07-22

Clinical Research of Perioperative Serum VEGF Level in Patients with Non-small Cell Lung Cancer
HU Ying,LI Bao-lan,HAN Yi,YU Da-ping,GUO Yan-ling,SHI Guang-li,GAO Guang-kuo,SONG Chang-xing. Clinical Research of Perioperative Serum VEGF Level in Patients with Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2010, 37(5): 535-539. DOI: 10.3971/j.issn.1000-8578.2010.05.013
Authors:HU Ying  LI Bao-lan  HAN Yi  YU Da-ping  GUO Yan-ling  SHI Guang-li  GAO Guang-kuo  SONG Chang-xing
Affiliation:Department of General Beijing Chest Hospital,Beijing 101149, China
Abstract:Objective:To study the perioperative dynamic changes of serum VEGF level in non-small cell lung cancer (NSCLC) patients who undergo surgery. Methods:Serum VEGF level was detected in 21 patients with NSCLC who were undergoing surgery by ELISA(enzyme linked immunosorbent assay) method before operation and on postoperative day 1,7,14,21,28. At the same time 12 patients with pulmonary benign diseases treated by surgery were studied as the control. Thirty healthy volunteers served to define normal VEGF. Results:(1) Preoperative serum VEGF level(649.20ng/L) in the group of patients with NSCLC was significantly higher compared with the benign or healthy group (respectively:140.70 ng/L and 94.40ng/L,P =0.000). (2) Serum VEGF level was elevated after surgery and the peak was observed on postoperative day +14 (1963.6 ng/L) in NSCLC , the peak was significantly higher than the preoperative level (649.20ng/L) ( P =0.000). Then the levels dropped, but it was still significantly higher than the preoperative level( P =0.000) and the level of the benign disease at the same time ( P =0.000).(3) Tumor size and the differentiation were related to preoperative serum VEGF level ( P <0.05). Tumor size, TNM stages and lymph node metastasize correlated with the change of serum VEGF ( P <0.05). Conclusion:Conclusions Perioperative serum VEGF level was significantly elevated in patients with NSCLC. Tumor size and the differentiation correlated with preoperative serum VEGF level. Tumor size, TNM stages and lymph node metastasis related to the change of serum VEGF.
Keywords:Vascular endothelial growth factor  Non-small cell lung cancer  Enzyme linked immunosorbent assay  Perioperative
本文献已被 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号